Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting obesity-related dysfunction in hormonally driven cancers
    Review

    Rubinstein, M. M.; Brown, K. A.; Iyengar, N. M.
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)
    Journal Article

    Ruddy, K. J.; Zheng, Y.; Tayob, N.; Hu, J.; Dang, C. T.; Yardley, D. A.; Isakoff, S. J.; Valero, V. V.; Faggen, M. G.; Mulvey, T. M.; more...
    Breast Cancer Research and Treatment (2021)

    Fulltext@MSK | Save
  • Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
    Journal Article

    Bardia, A.; Tolaney, S. M.; Punie, K.; Loirat, D.; Oliveira, M.; Kalinsky, K.; Zelnak, A.; Aftimos, P.; Dalenc, F.; Sardesai, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer
    Journal Article

    Liu, Y. L.; Bager, C. L.; Willumsen, N.; Ramchandani, D.; Kornhauser, N.; Ling, L.; Cobham, M.; Andreopoulou, E.; Cigler, T.; Moore, A.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
    Journal Article

    Wong, W.; Brogi, E.; Reis-Filho, J. S.; Plitas, G.; Robson, M.; Norton, L.; Morrow, M.; Wen, H. Y.
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
    Journal Article

    Mao, N.; Zhang, Z.; Lee, Y. S.; Choi, D.; Agudelo Rivera, A.; Li, D.; Lee, C.; Haywood, S.; Chen, X.; Chang, Q.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
    Journal Article

    Mondaca, S.; Lebow, E. S.; Namakydoust, A.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Offin, M.; Tu, H. Y.; Murciano-Goroff, Y.; Xu, C.; more...
    Lung Cancer (2021)

    Fulltext@MSK | Save
  • Adjuvant trastuzumab emtansine versus paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT): A randomized clinical trial
    Journal Article

    Tolaney, S. M.; Tayob, N.; Dang, C.; Yardley, D. A.; Isakoff, S. J.; Valero, V.; Faggen, M.; Mulvey, T.; Bose, R.; Hu, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S. V.; Drill, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Does preoperative MRI accurately stratify early-stage HER2+ breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?
    Review

    Botty van den Bruele, A.; Ferraro, E.; Sevilimedu, V.; Hogan, M. P.; Javed-Tayyab, S.; Le, T.; Fornier, M. N.; Morrow, M.; Sacchini, V.
    Breast Cancer Research and Treatment (2021)

    Fulltext@MSK | Save